Our Testicular Mass Series; Retrospective Analysis of 150 Patients

Abstract

INTRODUCTION: We aimed to present the long-term oncological results of patients who underwent radical orchiectomy for testicular tumor. METHODS: The data of 150 patients who were admitted to our clinic with a preliminary diagnosis of testicular tumor and underwent inguinal radical orchiectomy between January 2010 and February 2022 were evaluated retrospectively. 141 patients whose pathology result was germ cell testicular tumor were included in the study. The primary aim of our study was to evaluate long-term survival outcomes. RESULTS: Eight (5.7%) of our patients had a history of cryptorchidism. Seventy-seven (54.6%) patients had tumors in the right testis, 58 (41.1%) patients had left testis, and 6 (4.3%) patients had synchronous or metachronous bilateral testicular tumors. Preoperative median AFP, ßHCG and LDH values of the patients were 3.6 ng/ml, 1.7 mIU/ml and 225 U/L, respectively. Postoperative median AFP and ßHCG values were 3.2 ng/ml and 0.1 mIU/ml, respectively. Fifty-fourpatients (38.2%) had lymph node involvement. The mean lymph node size was 2.32 cm. None of ourpatients had visceral organ involvement. During the mean follow-up period of 76 months, only 1 (0.7%) patient died due to testicular cancer. No death was observed in any of our patients due to any reason other than TC. DISCUSSION AND CONCLUSION: We can state that survival rates are high in centers where both surgical and medical/radiation therapy can be planned in coordination, even in patients with advanced testicular tumors.

Keywords

• long term
• survival
• testis
• tumour